HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

Rudich SM; Mongini PK; Perez RV; Katznelson S

首页> 外文期刊>Transplantation Proceedings >HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

【24h】

HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

机译：HMG-CoA还原酶抑制剂普伐他汀和辛伐他汀抑制人B淋巴细胞活化。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplantation Proceedings 》 |1998年第4期| 共4页
作者
Rudich SM; Mongini PK; Perez RV; Katznelson S;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科手术学 ;
关键词
B-Lymphocytes; Hydroxymethylglutaryl CoA Reductase Inhibitors pharmacology; B淋巴细胞; 淋巴细胞转化; 普伐他丁; 斯伐他汀;

机译：B-Lymphocytes;Hydroxymethylglutaryl CoA Reductase Inhibitors pharmacology;B淋巴细胞;淋巴细胞转化;普伐他丁;斯伐他汀;

相似文献

外文文献
中文文献
专利

1. HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation. [J] . Rudich SM, Mongini PK, Perez RV, Transplantation Proceedings . 1998 ,第4期

机译：HMG-CoA还原酶抑制剂普伐他汀和辛伐他汀抑制人B淋巴细胞活化。
2. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analy [J] . Pasha MK, Muzeeb S, Basha SJ, Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences . 2006 ,第3期

机译：分析五种HMG-CoA还原酶抑制剂-阿托伐他汀，洛伐他汀，普伐他汀，瑞舒伐他汀和辛伐他汀：药理学，药代动力学和分析概述以及开发用于药物制剂的新方法
3. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation. [J] . Xu H, Zeng L, Peng H, American Journal of Physiology . 2006 ,第5期

机译：HMG-CoA还原酶抑制剂辛伐他汀通过阻止RhoA激活，减轻了VEGF诱导的“由内而外”向细胞外基质的信号传导。
4. Structure-Based Rational Quest for Potential Novel Inhibitors of Human HMG-CoA Reductase by Combining COMFA 3D QSAR Modeling and Virtual Screening [C] . Qing Y.Zhang, Jian Wan, Xin Xu, 第三届国际分子模拟与信息技术应用学术会议 . 2007

机译：通过组合COMFA 3D QSAR建模和虚拟筛选对人类HMG-CoA还原酶的潜在新型抑制剂的基于结构的合理探索
5. New therapeutics for cerebral malaria: An investigation into the effect of HMG-CoA reductase inhibitors and anti-apoptotic strategies in experimental cerebral malaria. [D] . Helmers, Andrew. 2008

机译：脑部疟疾的新疗法：HMG-CoA还原酶抑制剂的作用和抗凋亡策略在实验性脑部疟疾中的研究。
6. Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin. [O] . H Y Pan, J Triscari, A R DeVault, 1991

机译：普萘洛尔与HMG-CoA还原酶抑制剂普伐他汀和洛伐他汀之间的药代动力学相互作用。
7. Long-Term Combination Therapy with an ACE Inhibitor, Captopril, and an HMG-CoA Reductase Inhibitor, Pravastatin, Is Beneficial for Hypercholesterolemic Hypertensives: an Observational Study [O] . Hiroshi SHIONOIRP, Izumi TAKASAKI, Futoshi SHIONOIRI 2004

机译：使用ACE抑制剂，卡托普利和HMG-COA还原酶抑制剂，普伐他汀的长期组合治疗对高胆固醇的高血压症有益：观察研究
8. Effects of HMG-COA Reductase Inhibitor Therapy on LDL Cholesterol Blood Levels inHyperlipidemia: A Longitudinal Retrospective Anlaysis Using a Department of Defense Integrated Database [R] . Lee-Ziegler, C. L. 1998

机译：HmG-COa还原酶抑制剂治疗对高脂血症LDL胆固醇血液水平的影响：纵向回顾性分析使用国防部综合数据库

HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

著录项

相似文献

相关主题

期刊订阅